Safety, Biomarker Study of RL-007 in Subjects With Schizophrenia
Status:
Recruiting
Trial end date:
2021-10-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety and effects on electrical activity in the
brain of an investigational drug (RL-007) for improving cognition in patients with
schizophrenia